InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
79.75
(
0.00%
)
Bitcoin
68,143.61
(
0.50%
)
Post# of 252706
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 75
Posts 4700
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Member Level

Re: DewDiligence post# 252285

Friday, 06/21/2024 2:00:49 PM

Friday, June 21, 2024 2:00:49 PM

Post# of 252706

What kind of trial design are you anticipating for the second phase-3?



SOL-R - which has three arms:

A) drug arm given once, then again at 6 months. No shams.

B) Eylea given per label (every 2 months)

C) Masking arm (1/2 size of other two arms) - Eylea given once, and again at 6 months. No shams.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up